Videos

Ivantis Goes After Canal-based MIGS

By Mario Admin | May 19, 2016

Ivantis was founded in 2007 by two coronary stent inventors to develop “the only minimally invasive microstent for glaucoma that dilates and scaffolds Schlemm’s canal.”…

Read More

Encore Vision Reports Positive Phase I/II Results

By Mario Admin | May 19, 2016

Results from a Phase I/Phase II study of EV06 ophthalmic solution for the treatment of presbyopia show “it works to restore bilateral near vision. It…

Read More

ReVision Optics Eyes Panel Discussion in Q3

By Mario Admin | May 18, 2016

The Raindrop Near Vision Inlay for the treatment of presbyopia boasts a 2-mm diameter, 80% water composition, the same refractive index as the natural cornea,…

Read More

Transcend Medical

By Mario Admin | May 18, 2016
Read More

From Mythbuster to Dealmaker

By Mario Admin | May 18, 2016

Barry Cheskin, CEO, president and co-founder of PowerVision, provides details on his company’s new partnership with Alcon. Video Highlights: 00:30 – Details on Alcon deal…

Read More
OIS@ASCRS - Companies To Watch - LensGen (2016)

LensGen

By Tom Salemi | May 18, 2016

LensGen is a clinical stage company developing an accommodating IOL (AIOL) that mimics the natural human lens and uses the eye’s natural accommodative mechanism to…

Read More
OIS@ASCRS - Companies to Watch - Allotex 2016

Allotex

By Mario Admin | May 18, 2016

The driving force behind Allotex was the observation that the potential interest in synthetic corneal inlay technology was being dampened by the persistent biocompatibility issue.…

Read More

Allergan Sees MIGS as “Ready to Explode”

By Mario Admin | May 17, 2016

Allergan purchased AqueSys (developer of the Xen Gel Stent) in a $20 million deal earlier this year. “Just a few years ago, the energy and…

Read More

Refocus VIS Requires No Compromise

By Mario Admin | May 17, 2016

Refocus Group’s goal, according to CEO Mike Judy, is to become the preferred surgical alternative for the treatment of presbyopia. The VisAbility Implant System (VIS)…

Read More

Five Novel Innovations from WTF@OIS

By Mario Admin | May 17, 2016

The “What’s the Future@OIS” session at OIS@ASCRS 2016 showcased five novel innovations in ophthalmology that are difficult to place into any existing categories of ophthalmic…

Read More

Device for Profoundly Blind Uses Tongue Electrodes

By Mario Admin | May 17, 2016

The profoundly blind form mental images of their surroundings from a variety of stimuli – touch, echo location, the their tip of cane or guide…

Read More

“Lifestyle” Drop Claims to Correct Presbyopia – for Six Hours

By Mario Admin | May 17, 2016

Presbyopia Therapies LLC is developing an eyedrop that can correct presbyopia for six hours or so before it wears off, co-founder Jim McCollum told OIS@ASCRS…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.